2025-10-20: DEUSG Antwerp
Meeting Details
Date & Time: 1.30pm CEST (local time Antwerp) October 20th 2025
In person location: Gorilla 3, A Room with a Zoo, Antwerp
Objectives
Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.
Zoom Link
Link: DEUSG Zoom Meeting Link
Meeting Recording
Attendees @Monica Harry @Alejandro Lopez Osornio @Linda Parisien Linda bird @Matt Cordell @Nicola Ingram @Kylynn Loi (Unlicensed) @herman muys @ benny van Bruwaewe @laila barrouhou @ claudine sombie @olivia dalleur @nadia ennader @ dougal Fleming @ Ann Parades @Elisabeth Serrot-Damatte
Online: @Shane Byrnes @yolaine Forget @Ricardo Aznar @Noelle Horan @sebastian Vasquez @Victoire Caryn @Mia van Dorp @Anne-Dominque Pham Dr. Agram Emma Flaherty Frederic Doc Jerry O’Sullivan @Julie Boutin @Julie James @Kari Heinonen @Krista Lilly @laura Solana @Maria Gomez @Muhammed Nordin @Hanne Fjeldstad Johansen @Paul Wright Stuart Abbott @Christine.Haas @Megan Berry @ Mattias Colliander @ Francois Lavoie @ Sylvia Thun
Discussion items
Description | Mins | Owner | Notes & Actions | |
|---|---|---|---|---|
| 1 | Opening | 10 min | Shane Byrnes & Alejandro Lopez Osornio |
|
| 2 | Less Granular Clinical Drug | 30 min | Guillermo Reynoso | Sharing an update on the sample set analysis underway |
| 3 | Multi-Component Clinical Drugs | 30 min | Guillermo Reynoso, Linda Bird | UK is interested, Canada and Argentina presented the experience. The process of assessing interest and support will continue. There were concerns about the complexity of modelling the complex cases, alternatively, maintaining the complex concepts as primitive concepts might be a more straightforward solution. |
| 4 | Member Country Updates | 10 min | Shane Byrnes | Updates from any members that want to share developments or initiatives underway in relation to implementation or use of the drugs model or drug extension |
| 5 | 2025 Substances Co-ordination Project | 15 min | Monica Harry | Update on the 2025 Substances work, and related collaborative authoring |
| 6 | Meeting Break | 30 min |
| Scheduled break 3.00pm - 3.30pm local time |
| 7 | Implementation Guide | 15 min | Alejandro Lopez Osornio | To discuss the development of an Implementation Guide for FHIR and the SNOMED Drug Model. The group expressed support to start work in this aspect. |
| 8 | Organisms | 15 min | Linda Bird | The group agrees on the value of a relationship linking substances with the organism it originated from, for extracts, whole organisms and for antigens. This will be discussed with the content team. |
| 9 | Adding |Dose form after transformation| to the Dose form concept model | 30 min | Linda Bird | Adding |Dose form after transformation| to the Dose form concept model General agreement, but complex cases would be one to many, many possible administrable dose forms for a single manufactured dose form. Australia: possibility of using more general dose form (liquid vs oral liquid) Julie: transforms are standard, administrable dose forms could potentially be created, but there are complex cases to consider. |
| 10 | Patches | 15 min | Linda Bird | Proposals around patches, how to represent reservoir size and release rate. The decision was to use presentation strength for patches, how to represent these other aspects? |
| 11 | AOB | 15min | All | Any Forum/Open topics for priority discussion by group members. |
Copyright © 2026, SNOMED International